9999999997-18-006606.txt : 20180625 9999999997-18-006606.hdr.sgml : 20180625 20180625134519 ACCESSION NUMBER: 9999999997-18-006606 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180625 DATE AS OF CHANGE: 20180625 ACTION DATE: 20180625 RECEIVED DATE: 20180625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 18916614 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC DATE OF NAME CHANGE: 20000208 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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